Home›Companies›Biotech & Pharma›AskY Therapeutics

AskY Therapeutics, Inc.

Updated Oct 27, 2026·Latest SEC filing Jun 4, 2024·Suggest an edit

About AskY Therapeutics

AskY Therapeutics is a private company based in Owings Mills, Maryland, incorporated in 2022 in Delaware. It has reported $740,000 raised in two offerings on Form D since January 2023.

Funding Rounds (SEC Form D)

First saleFiled with SECAmount soldInvestorsAvg. checkTermsFiling
May 21, 2024Jun 4, 2024$460,000of $1.5M target12$38,333EquityRule 506(b)Form D ↗
Dec 2, 2022Jan 17, 2023$280,000of $500K target10$28,000Debt, Securities on exerciseRule 506(b)Form D ↗
Total, two offerings$740,000

First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.

Leadership Team

Executive officers and directors listed on AskY Therapeutics's Form D filed Jun 4, 2024.

AK
Alexander Krupnick
President and director
Also a director at Recourse Biologics.
DW
Dan Watkins
Executive officer and director
Also a president and co-chief executive officer, director at Recourse Biologics.
JW
John Westwick
Director
Also an executive officer and director at Recourse Biologics.

Sources

  1. SECAskY Therapeutics, Inc. filing history